Open AccessClinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
Author(s) -
Nizar Al-Ani,
Faiq I. Gorial,
Dina Yasiry,
Fadya Al Derwibee,
Yasameen Abbas Humadi,
Nancy Sunna,
Ali AlJabban
Publication year - 2021
Publication title -
open access rheumatology
Language(s) - English
Resource type - Journals
ISSN - 1179-156X
DOI - 10.2147/oarrr.s300838
Subject(s) - etanercept , medicine , rheumatoid arthritis , rheumatology , population , referral , physical therapy , family medicine , environmental health
The development of evidence-based guidelines on early pharmacotherapeutic treatment of rheumatoid arthritis (RA) could be useful in Middle Eastern nations striving to improve outcomes in patients with this chronic, debilitating disease. Evidence obtained from local populations should inform such guidelines and therefore our aim was to use real-world data to evaluate the clinical responses of Iraqi patients with RA who received earlier or later treatment with the TNF inhibitor etanercept.